Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty

PHASE2CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Postoperative Pain
Interventions
DRUG

Bupivacaine HCl

150 mg Bupivacaine HCl

DRUG

SKY0402

600 mg SKY0402 (study drug)

Trial Locations (9)

1548

Regional Hospital Kladno, Kladno

10019

St. Luke's Roosevelt Hospital, New York

35209

West Alabama Research, Inc., Birmingham

43220

The Ohio State University Medical Center, Columbus

66250

Urazova Nemocnice Brno, Brno

67401

The Hospital Trebic, Třebíč

79430

Texas Tech University Health Science Center, Lubbock

92653

Accurate Clinical Trials, Inc., Laguna Hills

95616

California Clinical Research, Inc., Davis

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY